Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 1390

Sort by

Sort Order Select

Journal Articles

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

Julia J. Scarisbrick, Pietro Quaglino, Sean Whittaker, Martine Bagot, Emmanuella Guenova, Evangelia Papadavid, Henry Miles Prince, Jose A. Sanches, Denis R. Miyashiro, Octavio Servitje, Christiane Querfeld, Oleg Akilov, Arvind Arumainathan, Luke Bennett, Maxime Battistella, Kim Benstead, Emilio Berti, Marie Beylot-Barry, Anne-Marie Busschots, Richard Cowan, Reinhard Dummer, Giles Dunnill, Teresa Estrach, Felicity Evison, Abraham Bashir, Larisa Geskin, Ale Gru, Joan Guitart, Melba C. Herrera, Emillia Hodak, Steve Horwitz, Constanze Jonak, Claus-Detlev Klemke, Robert Knobler, Pam Mckay, Marta Marschalkó, Cesare Massone, Rubeta Matin, Christina Mitteldorf, Robert Novoa, Pablo Ortiz-Romero, Nicola Pimpinelli, Ramon M. Pujol, Annmari Ranki, Liisa Vakeva, Kerri E. Rieger, Rudolf Stadler, Franz Trautinger, Johanna Latzka, Maarten Vermeer, Rachel Wachsmuth, Sophie Weatherhead, Ulrike Wehkamp, Marion Wobser, Youn H. Kim

Blood (2025) 146 (14): 1687–1692.

https://doi.org/10.1182/blood.2025029628

Published: 2025

Includes: Supplemental data

Journal Articles

Clinical and molecular features of immunodeficiency in patients with telomere biology disorders

Luiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, Xiaoyang Ma, Ivana Darden, Tania Machado, Yue Zhang, Neelam R. Redekar, Natthakan Thongon, Simona Colla, Geraldine Aubert, Cynthia E. Dunbar, Colin O. Wu, Neal S. Young, Bhavisha A. Patel, Fernanda Gutierrez-Rodrigues, Emma M. Groarke

Blood (2025) 146 (10): 1187–1193.

https://doi.org/10.1182/blood.2024026735

Published: 2025

Includes: Supplemental data

Journal Articles

Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma

Blood (2025) 146 (9): 1088–1095.

https://doi.org/10.1182/blood.2025028375

Published: 2025

Includes: Supplemental data

Journal Articles

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

Blood (2025) 146 (8): 964–970.

https://doi.org/10.1182/blood.2025029234

Published: 2025

Includes: Supplemental data

Journal Articles

ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia

Matthew S. Davids, Saad S. Kenderian, Ian Flinn, Brian T. Hill, Michael Maris, Paolo Ghia, Michael Byrne, Nancy L. Bartlett, John M. Pagel, Yan Zheng, Justyna Kanska, Wangshu Zhang, Enrique Granados, Javier Pinilla-Ibarz

Blood (2025) 146 (8): 938–943.

https://doi.org/10.1182/blood.2024027460

Published: 2025

Includes: Supplemental data

Journal Articles

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

Eduard Schulz, Lauren M. Curtis, Noa G. Holtzman, Seth M. Steinberg, Kaska Wloka, Alen Ostojic, Alain Mina, Najla El Jurdi, Filip Pirsl, Ashley Carpenter, Mahshid Golagha, Arlene Sirajuddin, Theo Heller, Brian C. Shaffer, Frances T. Hakim, Jeffrey S. Rubin, Ronald E. Gress, Steven Z. Pavletic

Blood (2025) 146 (8): 944–950.

https://doi.org/10.1182/blood.2024028303

Published: 2025

Includes: Supplemental data

Journal Articles

Eliminating the need for sequential confirmation of response in multiple myeloma

Blood (2025) 146 (7): 802–805.

https://doi.org/10.1182/blood.2024027949

Published: 2025

Includes: Supplemental data

Journal Articles

Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI

Dawei Chen, Huaqin Liang, Xiuzhang Xu, Wenjie Xia, Xin Ye, Yalin Luo, Jiansen He, Yaori Xu, Jing Liu, Hui Ren, Shengxue Luo, Trent M. Woodruff, Wioleta M. Zelek, B. Paul Morgan, Rick Kapur, Sentot Santoso, Yongshui Fu

Blood (2025) 146 (6): 759–764.

https://doi.org/10.1182/blood.2024028012

Published: 2025

Includes: Supplemental data

Journal Articles

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

Blood (2025) 146 (5): 585–589.

https://doi.org/10.1182/blood.2024027175

Published: 2025

Includes: Supplemental data

Journal Articles

Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis

Yiyao Catherine Chen, Naveen Eugene Louis Richard Louis, Angela Huang, Allan Sun, Alexander Dupuy, Laura Moldovan, Tiana Pelaia, Jianfang Ren, Taylor S. Cohen, Sarah C. Gilbert, Huyen Tran, Karlheinz Peter, James D. McFadyen, Lining Arnold Ju

Blood (2025) 146 (4): 496–503.

https://doi.org/10.1182/blood.2024027675

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Cs a /Cs b red cell antigens

Blood (2025) 146 (2): 247–253.

https://doi.org/10.1182/blood.2024026285

Published: 2025

Includes: Supplemental data

Journal Articles

Cell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2 -mutant MDS stem/progenitor cells

Kouhei Takashima, Malgorzata Olszewska, Vrinda Jethalia, Maria Sirenko, Lewis Silverman, Lewis E. Tomalin, Saul Carcamo, Dan Hasson, Eirini P. Papapetrou

Blood (2025) 146 (1): 115–122.

https://doi.org/10.1182/blood.2024025670

Published: 2025

Includes: Supplemental data

Journal Articles

The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Blood (2025) 145 (25): 3007–3014.

https://doi.org/10.1182/blood.2024026455

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma

Blood (2025) 145 (23): 2762–2767.

https://doi.org/10.1182/blood.2024026831

Published: 2025

Includes: Supplemental data

Journal Articles

Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWF

Ciara Byrne, Soracha Ward, Jamie O’Sullivan, Alain Chion, Patricia Lopes, Bogdan Baci, Caoimhe Dowd, Darragh Jordan, Ross Baker, Roger J. S. Preston, Marco Monopoli, Peter L. Turecek, Maximilianos Kotsias, Jack Cheeseman, Alan B. Moran, Richard A. Gardner, Daniel I. R. Spencer, Ferdows Atiq, James S. O’Donnell

Blood (2025) 145 (23): 2768–2773.

https://doi.org/10.1182/blood.2024027038

Published: 2025

Includes: Supplemental data

Journal Articles

Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

Zachariah DeFilipp, Haesook T. Kim, Laura W. Knight, Suzanne M. O’Connor, Shilton E. Dhaver, Meghan White, Bhagirathbhai Dholaria, Mark A. Schroeder, Sumithira Vasu, Sameem Abedin, Jooho Chung, Areej El-Jawahri, Matthew J. Frigault, Steven McAfee, Richard A. Newcomb, Paul V. O’Donnell, Thomas R. Spitzer, Yi-Bin Chen, Gabriela S. Hobbs

Blood (2025) 145 (20): 2312–2316.

https://doi.org/10.1182/blood.2024028005

Published: 2025

Includes: Supplemental data

Journal Articles

Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data

Kazuya Sakai, Atsushi Hamamura, Yoshiko Yoshimura, Miyuki Abe, Yoshiyuki Ogawa, Kazuki Tanaka, Norimichi Hattori, Tazuko Tokugawa, Rie Kanai, Fumiyoshi Ikejiri, Masahiro Takeyama, Teruhisa Taoka, Naoki Fujita, Minoru Kanaya, Katsuyoshi Koh, Hiroshi Shiragami, Hidekazu Azumi, Kenki Saito, Masanori Matsumoto

Blood (2025) 145 (20): 2390–2395.

https://doi.org/10.1182/blood.2024027516

Published: 2025

Includes: Supplemental data

Journal Articles

The JAK2 46/1 haplotype influences PD-L1 expression

Gonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, Alejandra Leivas, Jesús Victorino, Roberto García-Vicente, Andrew J. Chase, Andrea Maidana, William J. Tapper, Rosa Ayala, Nicholas C. P. Cross, Joaquín Martínez-López, Miguel Manzanares

Blood (2025) 145 (19): 2196–2201.

https://doi.org/10.1182/blood.2023023787

Published: 2025

Includes: Supplemental data

Journal Articles

Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study

Blood (2025) 145 (17): 1870–1875.

https://doi.org/10.1182/blood.2024026700

Published: 2025

Includes: Supplemental data

Journal Articles

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

Blood (2025) 145 (16): 1780–1787.

https://doi.org/10.1182/blood.2024027342

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

Clinical and molecular features of immunodeficiency in patients with telomere biology disorders

Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

Eliminating the need for sequential confirmation of response in multiple myeloma

Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI

NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation

Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis

The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Cs a /Cs b red cell antigens

Cell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2 -mutant MDS stem/progenitor cells

The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma

Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWF

Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data

The JAK2 46/1 haplotype influences PD-L1 expression

Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only